PEC vs HeXun Biosciences: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and HeXun Biosciences (6986) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ HeXun Biosciences

0%+108%-60%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYHeXun BiosciencesYoY
Oct 2026NT$2.84 billion+102.0%NT$10.6 million-59.8%
Sep 2026NT$2.64 billion+100.0%NT$16.7 million-22.7%
Aug 2026NT$2.62 billion+105.4%NT$21.4 million+4.8%
Jul 2026NT$2.51 billion+92.6%NT$15.3 million+5.8%
Jun 2026NT$2.33 billion+94.9%NT$30.4 million+13.4%
May 2026NT$2.46 billion+108.5%NT$46.8 million+10.1%
Apr 2026NT$2.06 billion+68.3%NT$16.7 million-46.8%
Mar 2026NT$1.94 billion+64.4%NT$38.1 million+80.8%
Feb 2026NT$1.6 billion+56.7%NT$19.1 million+10.9%
Jan 2026NT$1.58 billion+49.8%NT$15.4 million+23.1%
Dec 2025NT$1.92 billion+69.9%NT$33.8 million+5.4%
Nov 2025NT$1.55 billion+53.0%NT$25 million-7.3%
Oct 2025NT$1.4 billion+53.6%NT$26.5 million+0.3%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16